With primary cHL tissues, interphase cytogenetic analyses confirmed monoallelic deletion of TRAF3 in 3/20 cases and gains of MAP3K14 in 5/16 cases. This evidence concerns the gene MAP3K14 and classic Hodgkin lymphoma.